+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

BREO ELLIPTA Drug Profile, 2019

  • ID: 4726935
  • Report
  • 165 pages
  • thinkBiotech LLC
1 of 5

FEATURED COMPANIES

  • Glaxosmithkline Llc
  • MORE
BREO ELLIPTA Drug Profile, 2019 is part of a deep library of business intelligence on biopharmaceutical drugs.

The report focuses on BREO ELLIPTA and covers the following critical aspects of this drug:
  • United States patents
  • Expired United States patents
  • District Court patent litigation
  • European supplementatry protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Annual sales revenues
  • Finished product suppliers
About the Researcher

The researcher is a provider of global business intelligence on biologic and small-molecule drugs, dedicated to helping clients make better decisions. Critical information on global drug patents is incorporated with litigation intelligence, drug prices, and historic sales figures to help users discover commercial opportunities and forecast future revenue events. Since 2005 the researcher has served hundreds of large and small companies in more than 65 countries.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Glaxosmithkline Llc
  • MORE
  • Profile for BREO ELLIPTA
  • US Patents
  • US Regulatory Exclusivity
  • Expired US Patents
  • US District Court Litigation
  • International (ex US) Patents
  • Supplementary Protection Certificates
  • Clinical Trials
  • Drug Prices - Average Pharmacy Cost
  • Annual Sales Revenues
  • Finished Product Suppliers
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Glaxosmithkline Llc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4726935
Adroll
adroll